Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05975658
Other study ID # STUDY00002554
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date September 30, 2023
Est. completion date November 1, 2024

Study information

Verified date June 2024
Source Children's Mercy Hospital Kansas City
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A mixed-methods study will be used to evaluate the use of standard of care periodic pulse oximetry by parents/LAR and the feasibility of the collection of physiologic data related to the use of the Pediarity System. This system includes the Gabi Band and software platform (Gabi Analytics).


Description:

After enrollment, parents will be taught by the study team on the use of the Pediarity System which includes the placement of the Gabi Band and the use of the Gabi Wi-Fi monitor application for data transfer. This education by the study team will ensure uniform training and preliminary understanding with teach back on the use of the Gabi band and Gabi Wi-Fi monitoring application. Parents can ask the study team any use and/or technical questions during this time period. All clinical care questions from standard of care monitoring will go to the CHAMP healthcare team. If parents/LARs have a clinical concern from a value on the Pediarity System - they will be referred to use their standard of care pulse oximetry before any clinical intervention and care is recommended by the healthcare team. The study team will not make any healthcare or diagnostic recommendations during the monitoring period based on any Pediarity System data. The study team will educate parents and LARs on the Pediarity System. This system does not replace any use of their standard of care pulse oximetry and CHAMP videos. Parents may place the Gabi band on their child and use the Pediarity System at any frequency they choose in the home setting for a length of approximately one month at home (to coordinate when they return to the study site for a care visit). Parents can email or Teams call the study team directly (during daytime hours M-F) for any technical questions during this the study period. The study team will evaluate clinical data only at the conclusion of the study period and qualitative feedback from the parents will be gathered.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 15
Est. completion date November 1, 2024
Est. primary completion date July 30, 2024
Accepts healthy volunteers No
Gender All
Age group N/A to 2 Years
Eligibility Inclusion Criteria: - Study participants will be parent-child dyads - pediatric patients who have been diagnosed with congenital, arrhythmic, or acquired heart disease at Children's Mercy Kansas City. - Age criteria for children: after birth and who are less than two years of age at the time of being approached. - The child of the parent-child dyad must be planned from the clinical standpoint prior to approach for discharge home with standard of care oxygen saturation/heart rate/pulse oximeter for remote patient monitoring population - and followed with the CHAMP application in the home setting. - CHAMP App CM IRB 15030113 - Pediatric patients may be followed by the CHAMP Clinical team or enrolled in the CHAMP App Cardiac Study Exclusion Criteria: - Over two years of age at the time of being approached for study participation. - Families that do not speak English or Spanish (languages supported by the devices). - Families that do not have access to a Wi-Fi network at home.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Gabi SmartCare Pediarity System [Gabi Band, Gabi Monitor App, Gabi Analytics]
Gabi SmartCare has created a monitoring system named Pediarity System that obtains pediatric vitals data through non-invasive means through a Gabi band. When paired with a proprietary algorithm and software - Gabi Analytics - the cloud-based platform measures blood oxygen levels, pulse rate (and variability), respiratory rate, actigraphy, inter-beat interval, and tracking for the time the device is worn (or not worn by the child). Three LEDs on the monitor are used for capturing this information. Peak wavelengths for the red, infrared, and green LEDs operate at 660nm, 950nm, and 526nm respectively. The Gabi band features an optical front end coupled with an analog front end using 24 bits. Bluetooth data transmission is utilized on a mobile phone application with a tablet-based system in a CSV format for the purpose of offline data processing.

Locations

Country Name City State
United States Children's Mercy Hospital Kansas City Missouri

Sponsors (2)

Lead Sponsor Collaborator
Children's Mercy Hospital Kansas City Gabi SmartCare

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Parental Experience Evaluation Rigorously explore the parental experience of utilizing a continuous pediatric wireless device for monitoring at home pulse oximetry compared with standard of care periodic pulse oximetry through parent interviews. 3-6 Weeks
Secondary Data Transfer Rate Evaluation Evaluate the rate of data transfer from a wireless continuous monitoring device night ± daytime vs. standard of care periodic pulse oximetry. 3-6 Weeks
Secondary Stakeholder Experience Assessment Assess the technology experience for stakeholders with a wireless continuous monitoring device at home vs. standard of care periodic pulse oximetry using healthcare provider interviews to discuss outcome experience. 3-6 Weeks
Secondary Data Threshold Event Rate Evaluation Evaluate the rate of data threshold events with continuous remote device monitoring at home vs. intermittent pulse oximetry via standard of care periodic pulse oximetry. 3-6 Weeks
Secondary Satisfaction with the System Using the System Usability Survey (SUS) Strongly Disagree to Strongly Agree 1-7 3-6 weeks
Secondary Effectiveness with the System Using the System Usability Survey (SUS) Strongly Disagree to Strongly Agree 1-7 3-6 weeks
Secondary Comfort with the System Using the System Usability Survey (SUS) Strongly Disagree to Strongly Agree 1-7 3-6 weeks
Secondary Easy to use the System Using the System Usability Survey (SUS) Strongly Disagree to Strongly Agree 1-7 3-6 weeks
Secondary Easy to find information within the System Using the System Usability Survey (SUS) Strongly Disagree to Strongly Agree 1-7 3-6 weeks
Secondary Visualization of information within the System Using the System Usability Survey (SUS) Strongly Disagree to Strongly Agree 1-7 3-6 weeks
Secondary Clear organization of information within the System Using the System Usability Survey (SUS) Strongly Disagree to Strongly Agree 1-7 3-6 weeks
Secondary Functions of the System Using the System Usability Survey (SUS) Strongly Disagree to Strongly Agree 1-7 3-6 weeks
See also
  Status Clinical Trial Phase
Completed NCT03921346 - Reducing Prehospital Medication Errors & Time to Drug Delivery by EMS During Simulated Pediatric CPR N/A
Not yet recruiting NCT04087070 - Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
Completed NCT04301206 - Videos and Simple Text to Empower Parents to Handle Their Sick Children N/A
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05480930 - Improving Nighttime Access to Care and Treatment; Part 4-Haiti N/A
Not yet recruiting NCT05815563 - Validation of Peripheral Perfusion Index in Predicting Successful Supraclavicular Brachial Plexus Block in Pediatrics
Recruiting NCT02556541 - Ultrasound-guided Peripheral Vascular Access in Children N/A
Recruiting NCT02908113 - Visual Perception in Preterm Infants N/A
Not yet recruiting NCT01678066 - A Prospective Study to Bilaterally Compare a Non-Invasive Cardiac Output Monitor N/A
Completed NCT04993599 - Evaluation of Social Robot Usability for Pediatric Patients and Carers N/A
Completed NCT05537168 - Bayesian Networks in Pediatric Cardiac Surgery
Completed NCT01603628 - BOTOX® Treatment in Pediatric Lower Limb Spasticity Phase 3
Completed NCT01603615 - BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity Phase 3
Completed NCT06098105 - Laparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block vs Laparoscopic Intraperitoneal Instillation of Local Anesthetic in Pediatrics N/A
Completed NCT01418846 - Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients N/A
Completed NCT01460329 - Comparing Cardiac Output Measurements in Critically Ill Children Using USCOM and Transthoracic ECHO N/A
Withdrawn NCT00666393 - An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients Phase 3
Recruiting NCT03337581 - Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric Phase 4
Recruiting NCT05275881 - Impact of Virtual Reality in Pediatric Hematology and Oncology N/A
Recruiting NCT06146465 - Mobile Health Applications in Pediatric Patient Management: Clinicians' Perceptions, Expectations and Experiences

External Links